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Danger signals released by damaged organelles can promote inflammation. In this issue of Immunity,
Shimada et al. (2012) report that oxidized DNA, released by mitochondria, directly binds and activates the
NLRP3 inflammasome.Inflammasomes are cytosolic multiprotein
complexes that sense pathogens and
cellular damage to promote inflammation.
These molecular machines assemble
upon oligomerization of a scaffold protein
that detects specific insults and leads
to the activation of a central proteolytic
enzyme, caspase-1 (Martinon et al.,
2009). The main function of inflamma-
somes is the cleavage and maturation of
a few key cytokines, mainly interleukin-
1b (IL-1b) and IL-18. Upon maturation,
these cytokines are released and con-
tribute to the initiation of immune and
inflammatory cascades. Remarkable
diversity exists in the type of scaffolding
proteins that form the inflammasome-
sensing platforms. This diversity leads
to the assembly of different types of
inflammasomes specialized in the recog-
nition of various signals. The nucleotide
binding domain and leucine-rich repeat
pyrin 3 domain (NLRP3) (also known as
NALP3) scaffold protein orchestrates the
formation of the best-characterized
inflammasome thus far. A broad range of
stimuli have been shown to activate
NLRP3, including pathogens of virtually
every kind such as bacteria, viruses,
helminthes, and fungi. The NLRP3 in-
flammasome is also triggered by several
danger signals including pore-forming
toxins from bacteria, danger signals
released by damaged or stressed cells,
aswell asmicroparticles from the environ-
ment such as asbestos and silica (Menu
and Vince, 2011).
The molecular mechanisms by which
these different stimuli signal the assembly
and activation of the NLRP3 inflamma-
some are still largely unknown. None of
these stimuli have been found to bind or
act as direct agonists of NLRP3; however,
a few featureswere reported to be consis-tently associated with NLRP3 activation.
Many studies have demonstrated that
potassium (K+) efflux is a common feature
triggered by most NLRP3 inducers
including extracellular ATP, microparti-
cles, and nigericin, a known K+ ionophore
that promotes inflammasome activation.
The generation of reactive oxygen
species (ROS) is another common feature
elicited by most NLRP3 activators that is
required for inflammasome activation.
The source of ROS produced by proin-
flammasome mediators as well as the
role of ROS in the assembly of the
NLRP3 inflammasome has been a source
of debate in recent years. More recently,
efforts to identify NLRP3 ligands led to
the discovery of a NLRP3 binding protein,
TXNIP. However, the function of this
protein in regulating inflammasomes is
poorly understood and it is still unclear
whether TXNIP is an essential component
of NLRP3-activating pathways in macro-
phages (Tschopp, 2011).
A study in this issue of Immunity by
Shimada et al. (2012) links K+ efflux and
ROS production with the generation of
oxidized mitochondrial DNA and shows
that subsequent release of oxidized DNA
in the cytosol may directly act as a
NLRP3 agonist to promote inflamma-
some assembly. These observations
are consistent with two recent reports
demonstrating that mitochondria are
central to NLRP3 activation (Nakahira
et al., 2011; Zhouet al., 2011) andprovides
us with a coherent model of NLRP3 in-
flammasome activation (Figure 1).
In line with previous studies, Shimada
et al. (2012) show that NLRP3 activators,
such as extracellular ATP or nigericin,
disrupted mitochondrial function as re-
vealed by the alteration of the inner mito-
chondrial membrane potential, a markerImmunity 3of mitochondrial damage mostly associ-
ated with apoptosis. Importantly, mito-
chondrial potential decrease did not
require inflammasome components but
was abolished by compensating cellular
potassium efflux with the addition of
extracellular potassium. Therefore, loss
of mitochondrial potential is a possible
consequence of potassium efflux func-
tioning upstream of inflammasome
assembly. Potassium is the main intracel-
lular ion and plays a key role in keeping
mitochondrial matrix volume and func-
tion. It is therefore tempting to speculate
that cellular perturbations in potassium
flux may affect the osmotic balance
between the cytosol and the mitochon-
drial matrix, possibly contributing to
the generation of NLRP3-activating
mitochondrial danger signals.
Dysfunctional mitochondria are emerg-
ing as the key feature leading to NLRP3
activation, but the exact nature of the
NLRP3-activating mitochondrial signal
is still unclear (Tschopp, 2011). Both
activation of mitochondrial ROS and the
release of mitochondrial DNA have been
proposed to mediate NLRP3 inflamma-
some activation (Nakahira et al., 2011;
Zhou et al., 2011). Mitochondrial DNA
consists of a double-stranded 16.5 kb
circular molecule that is attached to the
inner mitochondrial membrane on
the matrix side in close proximity to a
major source of cellular ROS: the com-
ponents of the oxidative phosphorylation
machinery. Mitochondrial DNA is there-
fore particularly prone to oxidative
damage. This prompted Shimada et al.
(2012) to examine whether oxidized mito-
chondrial DNA drives NLRP3 activation.
Indeed, they found several indications
suggesting that oxidized mitochondrial
DNA directly acted as a NLRP3 agonist.6, March 23, 2012 ª2012 Elsevier Inc. 313
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Figure 1. Model of NLRP3 Inflammasome Assembly and Activation
NLRP3 inflammasome activators such as extracellular ATP and nigericin
trigger potassium efflux, loss of mitochondrial membrane potential, and mito-
chondrial ROS production. These events result in the oxidation of mitochon-
drial DNA and its release into the cytosol. Binding of oxidized DNA to
NLRP3 promotes assembly and oligomerization of the inflammasome. The
recruitment of the adaptor ASC and the enzyme caspase-1 to the inflamma-
some are crucial for its pro-IL-1b and pro-IL-18 cleaving activity.
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of 8-hydroxy-guanosine (8-
OH-dG), an oxidized deriva-
tive of guanosine and a major
product of DNA oxidation,
they found increased mito-
chondrial DNA oxidation in
macrophages treated with
NLRP3 agonists. They also
confirmed the rapid release
of mitochondrial DNA by
monitoring the appearance of
mitochondrial sequences in
the cytosol of stimulated cells.
These experiments clearly
identified oxidized mitochon-
drial DNA as a danger signal
released into the cytosol. The
dangerous nature of this
molecule relies on aberrant
localization (i.e., in thecytosol)
and oxidation, which tags the
molecule as damaged.
Shimada et al. (2012)
report that transfection of
both oxidized and nonoxi-
dized mitochondrial DNA in
macrophages triggered IL-
1b maturation. Moreover, by
using macrophages deficient
for AIM2, a known inflamma-
some-forming scaffold that
senses DNA, they demon-
strated that nonoxidized
DNA inflammasome activity
is AIM2 dependent whereas
oxidized DNA-mediated IL-
1b maturation is not affected
by AIM2 deficiency. Con-
versely, in NLRP3-deficient
macrophages, IL-1b matura-
tion was reduced after
oxidized DNA stimulation,
showing that NLRP3 may
account for at least some
of the inflammasome acti-
vity triggered by oxidized
DNA present in the cytosol.During the initiation phase of apoptosis,
loss of mitochondrial membrane potential
leads to the release of cytochrome c into
the cytosol. Cytochrome c then directly
binds and activates the apoptosome
complex leading to caspase activation.
By analogy, this raises the possibility
that cytosolic mitochondrial DNA could
directly bind and activate the NLRP3
inflammasome. In line with this model,
Shimada et al. (2012) have shown that314 Immunity 36, March 23, 2012 ª2012 Elseupon transfection, the NLRP3 protein
interacts and colocalizes with DNA.
Surprisingly, both oxidized and nonoxi-
dized DNA bound NLRP3, indicating that
NLRP3 cannot discriminate between
these two forms of DNA, which is in
contradiction with the observation that
nonoxidized DNA fails to activate
NLRP3. This could suggest that although
both forms bind NLRP3, only oxidized
DNA can promote the conformationalvier Inc.changes required for inflam-
masome assembly. Alterna-
tively, the promiscuity ob-
served in binding could be
the result of experimental
limitations promoting non-
physiological interactions be-
tween NLRP3 leucine-rich
repeats and DNA.
The inhibition of autophagy
prevents the disposal of dam-
aged mitochondria, thereby
boosting NLRP3 inflamma-
some activity (Nakahira et al.,
2011). By using autophagy
inhibitors in the presence of
NLRP3 agonists, Shimada
et al. (2012) detected endoge-
nous binding of oxidized mito-
chondrial DNA with NLRP3.
This suggests that under
those conditions, sufficient
amounts of DNA reach the
cytosol to form a detectable
complexwith NLRP3. Further-
more, the binding of DNA to
NLRP3 was inhibited by 8-
OH-dG that was found in
complex with NLRP3, indi-
cating that free oxidized
nucleobases compete with
DNA for NLRP3 binding but
are not able to trigger NLRP3
activation per se. Although
these findings provide rea-
sonable evidence that mole-
cules of oxidized DNA bind
NLRP3, it is unclear whether
DNA is part of the active
inflammasome complex or
only plays a role in the early
priming of NLRP3 prior to its
oligomerization. Moreover, it
remains to be determined
whether DNA binding is regu-
lated by, or affects, NLRP3
binding to other proteins
such as SGT1 or TXNIP. Abetter molecular characterization of these
interactions and the identification of
the domains involved in DNA binding
may shed some new light on the mecha-
nisms of inflammasome assembly and
activation.
The article by Shimada et al. (2012) also
raises additional enigmatic issues that
remain to be resolved. For example, it is
unclear whether the release of oxidized
mitochondrial DNA is a universal feature
Immunity
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release by dying inflammasome-compe-
tent cells to promote tissue injury-
mediated inflammation, or whether the
release of oxidized mitochondrial DNA
and NLRP3 activation can occur in the
absence of apoptosis. Although the mito-
chondria is emerging as a key organelle
that senses cellular insults to promote
inflammatory responses, the role of
potassium efflux and the mechanisms
that drive mitochondrial ROS production
and control the release of mitochondrial
DNA are still unknown. Finally, it remains
to be determined whether release of
mitochondrial DNA into the circulation
upon tissue injury (Zhang et al., 2010)
could contribute to inflammasome activa-
tion by recruited phagocytes, therebycontributing to inflammatory responses.
Given the important role of the NLRP3
inflammasome in various human patholo-
gies, the answer to these questions will
probably provide better overall under-
standing of the mechanisms that translate
cellular stress into an inflammatory
reaction. In Choderlos de Laclos’s
novel Dangerous Liaisons, relationships
are used as weapons in a game of power
and revenge that eventually takes a tragic
course. By analogy, when mitochondrial
DNA encounters and interacts with
NLRP3, it initiates a complex cascade of
events that start with inflammasome
formation and promotes self-defenses
or, in a dramatic twist worthy of Laclos,
backfires into a dangerous and harmful
inflammation.Immunity 3REFERENCES
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B cell antibody production is thought to be crucial for protection against virus infection. In this issue of
Immunity, Moseman et al. (2012) illustrate an antibody-independent role for B cells in macrophage activation
that prevents virus dissemination after subcutaneous infection.The production of neutralizing antibodies
by B cells to protect against viral and
bacterial infections is a hallmark of immu-
nity and one of the primary goals of vacci-
nation. However, recent reports including
a paper in this issue of Immunity have re-
vealed an additional previously unappre-
ciated critical function of B cells as regula-
tors of innate immunity to virus infection.
For some viruses, the very earliest events
after infection that lead to virus clearance
are not well defined.Whereas pre-existing
‘‘natural’’ antibody may in some cases
provide some degree of initial protec-
tion, the innate immune system including
macrophages, NK cells, and neutrophils
are believed to be central to limiting initial
pathogen spread while the adaptive im-
mune response ramps up. Moreover,
cytokines, in particular type I interferons,
are key to early protection against virusinfection. Thus, in the absence of type I
interferon receptor signaling, mice are
exquisitely sensitive to infection with a
number of viruses including vesicular
stomatitis virus (VSV) and mouse cyto-
megalovirus (MCMV) (Garcı´a-Sastre and
Biron, 2006). While plasmacytoid den-
dritic cells (pDCs) triggered through
pattern recognition receptors, particularly
TLRs, produce copious amounts of IFN-a
in response to virus infection, many other
cell types also have the ability to produce
and respond to type I interferons. Never-
theless, the precise mechanisms by
which IFN is induced, especially with re-
gard to the initial cell types that encounter
and potentially harbor virus replication,
are unclear.
In addition to TLR-mediated IFN-a
induction, TLR-independent pathways
for driving IFN-a production have alsobeen described (Delale et al., 2005). For
example, the IFN-b response after CMV
infection has been shown to be regulated
by lymphotoxin (LT) produced by hemato-
poietic cells. In the absence of LTab-LTbR
signaling, mice are highly susceptible to
intravenous MCMV infection, resulting in
large part from poor induction of type I
interferons (Benedict et al., 2001). Re-
markably, the relevant source of LTb
is the splenic B cell (Schneider et al.,
2008). Bone marrow chimera recon-
stitution studies further revealed that the
responding cell type is a stromal cell of
nonhematopoietic origin. Thus, B cell-
derived LTb acting on a potentially in-
fected stromal cell drives IFN-b produc-
tion that leads to early protection against
infection. Additionally, this pathway of
IFN production is independent of TLR
signaling. Considering that these events6, March 23, 2012 ª2012 Elsevier Inc. 315
